2004 News Listings                                                                                            Pages 1 - 2 - 3 - 4                       > View archives 2002 - 2003 9/30/04 Memory Pharmaceuticals Appoints Peter F. Young to Board of Directors 9/30/04 Diversa Launches Novel Vaccine Product for Salmon Aquaculture 9/23/04 Advancis Pharmaceutical To Begin Inaugural PULSYS Phase III Trial 9/22/04 Alien Technology Announces European RFID Solutions Operating to Latest ETSI UHF Frequency Regulations 9/16/04 Memory Pharmaceuticals Announces the Appointment of David A. Lowe, Ph.D. as Chief Scientific Officer 9/16/04 American Heart Association Adds A-HeFT Heart Failure Study To Late-Breaking Plenary Session 9/07/04 Technology Veteran Jim Cady Joins LightPointe as President and Chief Executive Officer 9/01/04 First Day of Business for Symetra Financial 8/12/04 ON24 Announces Record 1st Half - 76% Revenue Growth over last year 7/19/04 NitroMed Stops Heart Failure Study (A-HeFT) in African Americans Due to Significant Survival Benefit of BIDIL 7/1/04 Advancis Pharmaceutical Acquires Keflex Brand from Lilly 6/30/04 iVillage Inc. Announces Common Stock Offering 6/22/04 Inotek Pharmaceuticals Announces Designation of INO-1001 as a Fast Track Product for the treatment of patients with ST elevated Myocardial Infarction 6/22/04 Merck and NitroMed Advance First Nitric Oxide-Enhancing Cox-2 Inhibitor into Phase II Clinical Testing 6/21/04 Senomyx Announces Initial Public Offering 6/17/04 Good Results in Clinical Trial of Growth Drug (Tercica) 6/16/04 Tercica Announces rhIGF-1 Phase III Efficacy and Safety Data to be Presented at 86th Annual Endocrine Society Meeting 6/14/04 Mahi Networks Secures $70 Million in New Private Equity Funding 6/02/04 Advancis Pharmaceutical, Par Pharmaceutical Finalize Amoxicillin PULSYS Agreement 5/25/04 Inotek Pharmaceuticals Appoints Jeffrey Walsh as Vice President of Corporate Development and Commercial Planning 5/24/04 Inotek Pharmaceuticals Announces Designation of INO-1001 as a Fast Track Product for Complications associated with Thoracoabdominal Aortic Aneurysm Surgery 5/12/04 InnerWireless Gets $12M In Series B, Says Johnson Controls Is Investor
	Copyright ©2007 Rho Capital Partners, Inc.